A recent study suggests that individuals who discontinue blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise plans.
Findings released in a prominent health publication demonstrates that while obese individuals often shed substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"Individuals buying these medications should be cognizant of the potential of quick weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.
That rate of recovery means a reversion to pre-treatment weight in about a year and a half.
Analyzing Therapies
The research, which examined 37 of trials involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.
Scientists point out that individuals who shed pounds through lifestyle changes alone typically experience a more gradual creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Nutrition scientists propose the mode of action of the drugs explains the heightened weight return.
The injections imitate a natural hormone called GLP-1, which helps regulate appetite.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication leads to hunger is no longer kept in check, making excessive eating much more probable."
An Ongoing Disease?
Health authorities suggest the injections for individuals with weight-linked health risks, alongside recommended lifestyle changes.
Professionals say that, given the significant potential of weight regain, the treatment is often long-term.
This view is reinforced by pharmaceutical companies, who state that the results "emphasize the chronic character of excess weight," comparing it to managing conditions like diabetes.
Patient Accounts
Individuals who have discontinued the medication describe a powerful return of cravings.
"It felt as if something activating and you become starving," said a patient.
The struggle is exacerbated if patients have not developed lasting dietary or behavioural modifications during therapy.
Widespread Adoption
Figures suggest that millions of people in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Use is more common among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
Finally, experts caution that while the jabs are powerful agents for weight loss, they are not a magic cure and long-term success hinges on integrated behavioural changes.
